The IGA is an international umbrella group representing the interest of Gaucher patients and those of non-for-profit Gaucher patient groups as well as rare disease groups throughout the world.
Clinical Trial for Gaucher Disease Type 3
By National Gaucher Foundation
Sanofi Genzyme’s Phase 2 Clinical Trial to Evaluate Oral Substrate Reduction Therapy for Gaucher Disease Type 3
Sanofi Genzyme is investigating an orally …
read more »
© 2019 International Gaucher Alliance
Site managed by evergreencomputing.com